July 17, 2025
Tangible Assets

Kazia Therapeutics Announces Sale of Intellectual Property and Trademarks Rights for Cantrixil

Kazia to receive USD $1 million from Vivesto for the intellectual property and trademark assets rights to the oncology drug candidate, Cantrixil SYDNEY, March 31, 2025 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA) (“Kazia” or “the Company”), an oncology-focused drug development company, today announced the sale of all intellectual property and trademarks rights to Cantrixil

Read More
Fixed Assets

4 Manufacturing Tools Stocks to Watch on Prospering Industry Trends

The Zacks Manufacturing-Tools & Related Products industry is poised for growth on the back of robust demand for machinery tools in the industrial and automotive industries. Increased usage of electrical devices these days should drive demand for manufacturing tools in the power market. With rapid urbanization and the associated investments in product development and upgrades,

Read More